Tag: Cancer: Cervical
Many Older Women Not Eligible to Quit Cervical Cancer Screening
Findings consistent among women with employer-based insurance and those treated at a safety net health center
Lower Incomes Increase Cancer Worry, Anxiety During Pandemic
Worry, anxiety up with lower annual income for Medicaid-insured women receiving gynecologic oncology care during March 15 to April 15, 2020
Cervical Cancer Screening Rates Dropped During Stay-at-Home Order
Cervical cytology screening rates per 100 person-months decreased 78 percent among women aged 21 to 29 years
Breast, Cervical, CRC Screening Below Healthy People 2020 Targets
Colorectal cancer test receipt near target in 2018, with 66.9 percent of adults aged 50 to 75 years up to date with testing
Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19
Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black
Rate of Injuries Increased Around Diagnosis of Cervical Cancer
Rates of iatrogenic, noniatrogenic injuries higher for women having diagnostic workup for cervical cancer
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
Most Gynecologic Cancer Therapy Not Tied to Higher COVID-19 Risk
Only recent immunotherapy use linked to death due to COVID-19 in gynecologic oncology patients
ACS Issues Updated Guideline for Cervical Cancer Screening
Screening, preferably with primary HPV testing, should start at age 25 and continue through age 65
Artificial Intelligence Provides Benefit for Cervical Cancer Screening
Automated dual-stained slide evaluation reduces number of colposcopies versus current standards
